Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
IM Cannabis Corp ( (IMCC) ) just unveiled an update.
On January 5, 2026, IM Cannabis Corp. reported that it had appointed Alon Dayan to its board of directors, effective December 31, 2025, adding a seasoned technology and homeland security executive to its leadership. Dayan, currently CEO of KeepZone AI Inc. and founder-CEO of L1-Systems Ltd., brings more than 15 years of experience in systems integration, secure communications, international business development, and prior leadership roles in cybersecurity, defense electronics, and cryptocurrency technologies, potentially strengthening IM Cannabis’s strategic capabilities and international expansion efforts in its core medical cannabis markets of Israel and Germany.
The most recent analyst rating on (IMCC) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on IM Cannabis Corp stock, see the IMCC Stock Forecast page.
Spark’s Take on IMCC Stock
According to Spark, TipRanks’ AI Analyst, IMCC is a Neutral.
The overall stock score is primarily impacted by the company’s weak financial performance, characterized by ongoing losses and negative cash flows. Technical analysis provides a slightly positive outlook due to short-term momentum, but valuation concerns due to a negative P/E ratio and lack of dividends weigh heavily. The absence of earnings call data and corporate events means these factors do not influence the score.
To see Spark’s full report on IMCC stock, click here.
More about IM Cannabis Corp
IM Cannabis Corp. is an international medical cannabis company listed on Nasdaq that supplies premium cannabis products to patients in Israel and Germany. The company focuses on achieving sustainable, profitable growth in these two high-value markets, leveraging a transnational, data-driven ecosystem and a globally sourced supply chain. Its operations span importing and distributing medical cannabis, running retail pharmacies and online platforms in Israel, and distributing products to pharmacies in Germany through its subsidiary Adjupharm GmbH, all under stringent regulatory compliance.
Average Trading Volume: 556,358
Technical Sentiment Signal: Sell
Current Market Cap: $7.82M
See more data about IMCC stock on TipRanks’ Stock Analysis page.